oral P2Y12 inhibitors

Original Contribution

Safety of Intravenous Cangrelor Administration for Antiplatelet Bridging in Hospitalized Patients: A Retrospective Study

12/01/2021

Bryce V. Johnson, MD¹; Edward R. Horton, MD²; Christopher Domenico, PharmD³; Ashwin S. Nathan, MD³; Alexander C. Fanaroff, MD, MHS³; Michael A. Acker, MD⁴; Daniel M. Kolansky, MD³

Bryce V. Johnson, MD1; Edward R. Hort...

Bryce Johnson, MD and colleagues aimed to characterize outcomes associated with cangrelor administration used in an antiplatelet bridging strategy in real-world clinical scenarios within a large academic medical system.

Bryce Johnson, MD and colleagues...

12/01/2021

Journal of Invasive Cardiology